{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[12,2,12,3],[13,2,13,3],[17,2,17,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9911007090703321"]
[null,null,"Titolo",null,"Designing multi-target drugs / / edited by J. Richard Morphy, C. John Harris"]
[null,null,"Pubbl/distr/stampa",null,"Cambridge [England], : RSC Pub., 2012"]
[null,null,"ISBN",null,"9781621981435"]
[{"$nulls":4},"1621981436"]
[{"$nulls":4},"9781849734912"]
[{"$nulls":4},"1849734917"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (395 p.)"]
[null,null,"Collana",null,"RSC drug discovery series, , 2041-3203 ; ; 21"]
[null,null,"Disciplina",null,"615.19"]
[null,null,"Soggetti",null,"Drug targeting"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"i-iv; v-x; xi-xiv; xv-xviii; xix-xxviii; 1-13; 14-31; 32-49; 50-65; 66-85; 86-93; 94-110; 111-129; 130-140; 141-154; 155-180; 181-205; 206-220; 221-242; 243-262; 263-269; 270-289; 290-315; 316-334; 335-352; 353-355; 356-366"]
[null,null,null,"Sommario/riassunto","Multi-target drug discovery (MTDD) is an emerging area of increasing interest to the drug discovery community. Drugs that modulate several targets have the potential for an improved balance of efficacy and safety compared to single targets agents. Although there are a number of marketed drugs that are thought to derive their therapeutic benefit by virtue of interacting with multiple targets, the majority of these were discovered accidentally. Written by world renowned experts, this is the first book to gather together knowledge and experiences of the rational discovery of multi-target drugs. I"]